News & Trends - Pharmaceuticals

Target acquired: Merck and Omico set sights on fast-tracking precision cancer trials
Josie Downey, Managing Director of Merck Healthcare ANZ, and Professor David Thomas, Chief Science and Strategy Officer at Omico, unpack […]
MoreNews & Trends - Pharmaceuticals

Diagnosing the system, not just the patient: A rare alliance calls for reform
On Rare Cancers Awareness Day (26 June), Christine Cockburn, CEO of Rare Cancers Australia (RCA), and Paul Fenton, CEO of […]
MoreNews & Trends - Biotechnology

QBiotics reports promising data in rare cancer trial
On Rare Cancers Awareness Day (26 June), Australian biotech QBiotics Group unveiled the final efficacy and safety results from stage […]
MoreNews & Trends - MedTech & Diagnostics

Pressure pays off – for now: Health insurers to boost private hospital payouts
Private hospitals have welcomed a shift by health insurers to return more of the premium revenue to patients and providers, […]
More